SingHealth Duke-NUS Academic Medical Centre will NEVER ask you to transfer money over a call. If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg.
B. Med. Sc. (1st class Honors), M.B.B.S. (Medicine), Ph.D. (Medical Genetics)
Director, SingHealth Duke-NUS Institute of Biodiversity Medicine (BD-MED)
Deputy Chief Executive Officer (Research)
Deputy Director (Global Relations)
Professor, Duke-NUS Medical School, Singapore
Senior Principal Investigator, Institute of Molecular and Cell Biology, Singapore
Senior Group Leader, Genome Institute of Singapore
Professor Teh obtained his MD (1992) from the University of Queensland, Australia and his PhD (1997) from the Karolinska Institute, Sweden. He is currently the Deputy Chief Executive Officer (Research) of the National Cancer Centre of Singapore, and Director of SingHealth Duke-NUS Institute of Biodiversity Medicine (BD-MED).
He is a past and present member of the editorial boards / editor of Lancet Oncology, Cancer Research, Molecular Cancer Therapeutics, International Journal of Cancer and Science Translational Medicine. His laboratory has been focusing on Genomics and Epigenomics of Asian-Prevalent Cancers such as hepatobiliary cancer, herbal carcinogen-related cancer and breast fibroepithelial tumors. Dr Teh is a recipient of the 2015 Singapore President Science Award, 2018 AACR Team Science Award, and plenary lecturer at the 2019 AACR Annual Meeting.
Selected Publications (out of 416)
© 2025 SingHealth Group. All Rights Reserved.